Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
---|---|---|---|---|---|---|---|---|
CancerPDF_ID1710 | VKDISEVVTPR | Complement factor B | Serum | 1241.69795 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1711 | QLNEINYEDHKL | Complement factor B | Serum | 1514.73652 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1712 | KDISEVVTPR | Complement factor B | Serum | 1142.62954 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1713 | ALFVSEEEKK | Complement factor B | Serum | 1178.6183 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1714 | ALFVSEEEKKLTR | Complement factor B | Serum | 1548.85116 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1715 | VSEADSSNADWVTK | Complement factor B | Serum | 1507.67907 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1716 | QLNEINYEDHK | Complement factor B | Serum | 1401.65246 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1717 | VSEADSSNADWVTKQLNEINYEDHKL | Complement factor B | Serum | 3004.40502 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1718 | DISEVVTPR | Complement factor B | Serum | 1014.53457 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1719 | DNEQHVFK | Complement factor B | Serum | 1015.47231 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1720 | QLNEINYEDH | Complement factor B | Serum | 1273.55749 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1721 | EKLQDEDLGFL | Complement factor B | Serum | 1305.64525 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1722 | ALFVSEEEKKLT | Complement factor B | Serum | 1392.75005 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1723 | ALFVSEEEKKLTRK | Complement factor B | Serum | 1676.94612 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1724 | STGSWSTLKTQDQ | Complement factor B | Serum | 1437.67359 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1725 | ALFVSEEEK | Complement factor B | Serum | 1050.52334 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1726 | YGLVTYATYPKIWV | Complement factor B | Serum | 1672.88648 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1727 | GIPEFYDYDVALIKL | Complement factor B | Serum | 1754.91309 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID1728 | EAGIPEFYDYDVALIKL | Complement factor B | Serum | 1954.9928 | LC-MS | Colorectal cancer | NA | 21136997 |
CancerPDF_ID2927 | ISVIRPS | Complement factor B | Plasma | 770.465 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2928 | DNEQHVF | Complement factor B | Plasma | 887.3774 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2929 | GDSGGPLIVH | Complement factor B | Plasma | 950.4821 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2930 | VASYGVKPR | Complement factor B | Plasma | 975.5502 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2931 | LFVSEEEK | Complement factor B | Plasma | 979.4862 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2932 | DISEVVTPR | Complement factor B | Plasma | 1014.5346 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2933 | KDNEQHVF | Complement factor B | Plasma | 1015.4723 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2934 | ALFVSEEEK | Complement factor B | Plasma | 1050.5233 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2935 | KDISEVVTPR | Complement factor B | Plasma | 1142.6295 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2936 | ALFVSEEEKK | Complement factor B | Plasma | 1178.6183 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2937 | VKDISEVVTPR | Complement factor B | Plasma | 1241.698 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2938 | NEINYEDHKL | Complement factor B | Plasma | 1273.5939 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2939 | YGLVTYATYPK | Complement factor B | Plasma | 1274.6547 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2940 | LFVSEEEKKLT | Complement factor B | Plasma | 1321.7129 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2941 | GTDYHKQPWQA | Complement factor B | Plasma | 1329.6102 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2942 | LNEINYEDHKL | Complement factor B | Plasma | 1386.6779 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2943 | ALFVSEEEKKLT | Complement factor B | Plasma | 1392.7501 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2944 | QLNEINYEDHK | Complement factor B | Plasma | 1401.6525 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2945 | KGTDYHKQPWQA | Complement factor B | Plasma | 1457.7052 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2946 | QLNEINYEDHKL | Complement factor B | Plasma | 1514.7365 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2947 | LTRKEVYIKNGDK | Complement factor B | Plasma | 1562.878 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2948 | EAGIPEFYDYDVALIK | Complement factor B | Plasma | 1841.9087 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2949 | KEAGIPEFYDYDVALI | Complement factor B | Plasma | 1841.9087 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2950 | EAGIPEFYDYDVALIKL | Complement factor B | Plasma | 1954.9928 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2951 | DLEIEVVLFHPNYNINGK | Complement factor B | Plasma | 2113.0844 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID2952 | VSEADSSNADWVTKQLNEINYEDHKL | Complement factor B | Plasma | 3004.405 | LC-MS | Normal | NA | 21136997 |
CancerPDF_ID9596 | TPWSLARPQG | Complement factor B | Serum | 556.79 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
CancerPDF_ID10404 | TETIEGVDAEDGHGPGEQQ | Complement factor B | Urine | 1968.8631 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10524 | SSLTETIEGVDAEDGHGPGEQQ | Complement factor B | Urine | 2256.0136 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10593 | FLSSLTETIEGVDAEDGHGPGEQQ | Complement factor B | Urine | 2516.1478 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID10609 | AFLSSLTETIEGVDAEDGHGPGEQQ | Complement factor B | Urine | 2587.1776 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
CancerPDF_ID11485 | GHGPGEQQKRKIVLD | Complement factor B | Serum | 1660.9009 | LC-MS | Melanoma | "Present in 6 cancer samples out of 8 cancer samples. ,Present in 2 healthy samples out of 4 healthy samples." | 26992070 |